Equine pancreatic lipase antibody and antigen (recombinant protein)
Diagnostic anti-Equine pancreatic lipase antibodies pairs and antigen for animal health (animal Equine/Horse Pancreatitis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-pancreatic-lipase-Ag01 | Recombinant Equine pancreatic lipase protein | 3090 |
GMP-EQU-pancreatic-lipase-Ab01 | Anti-Equine pancreatic lipase mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-pancreatic-lipase-Ab02 | Anti-Equine pancreatic lipase mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-pancreatic-lipase-Ab03 | Anti-Equine pancreatic lipase human monoclonal antibody (mAb) | 1953 |
GMP-EQU-pancreatic-lipase-Ab04 | Anti-Equine pancreatic lipase human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-pancreatic-lipase-Ag01 |
Product Name | Recombinant Equine pancreatic lipase protein |
Target/Biomarker | Equine Pancreatic Lipase () |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine Pancreatic Lipase antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of animal Equine/Horse with Pancreatitis. |
Tag | His |
Products description | Recombinant Equine pancreatic lipase protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-pancreatic-lipase-Ab01, GMP-EQU-pancreatic-lipase-Ab02 |
Product Name | Anti-Equine pancreatic lipase mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine Pancreatic Lipase () |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine Pancreatic Lipase antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies in level test of animal Equine/Horse with Pancreatitis. |
Tag | mFc |
Products description | Anti-Equine pancreatic lipase mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-pancreatic-lipase-Ab03, GMP-EQU-pancreatic-lipase-Ab04 |
Product Name | Anti-Equine pancreatic lipase human monoclonal antibody (mAb) |
Target/Biomarker | Equine Pancreatic Lipase () |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine Pancreatic Lipase antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies in level test of animal Equine/Horse with Pancreatitis. |
Tag | hFc |
Products description | Anti-Equine pancreatic lipase human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Pancreatic lipase in horses is an enzyme produced by the pancreas that plays a crucial role in the digestion of dietary fats. It works specifically in the small intestine to hydrolyze triglycerides, which are the main form of dietary fats, into monoglycerides and free fatty acids. These products are then absorbed by the cells lining the intestinal tract and used by the body. Functions and Importance of Equine Pancreatic Lipase: Digestion of Fats: Pancreatic lipase is key to the efficient breakdown of triglycerides into absorbable units. Without this enzyme, fats would pass through the digestive system largely unprocessed, leading to fat deficiencies and malabsorption syndromes. Energy Source: The free fatty acids produced by the action of lipase serve as an important source of energy for horses. For performance horses, fat can provide a more concentrated source of energy compared to carbohydrates. Nutrient Absorption: The digestion of fats also enables the absorption of fat-soluble vitamins (A, D, E, and K) which are crucial for various bodily functions, including vision, blood clotting, and maintaining healthy skin and mucous membranes. Clinical Aspects and Applications: Exocrine Pancreatic Insufficiency (EPI): If the pancreas fails to produce adequate levels of pancreatic lipase, it can lead to EPI. While rare in horses, EPI can result in malabsorption, weight loss, and a dull coat due to the inability to properly digest and absorb fats. Diagnosis of Pancreatic Disorders: Measurement of pancreatic lipase can be used as a diagnostic tool in horses suspected of having pancreatic dysfunction. Elevated levels of lipase in the blood can indicate pancreatic inflammation or damage, although this is less commonly seen in equine practice compared to small animal practice. Lipase Supplements: In other animals, pancreatic enzyme supplements can be used to treat EPI, and while not common, they could theoretically be used in horses if necessary. Dietary Management: Horses typically do not have high-fat diets, but the introduction of dietary fats can be a strategy for providing high-energy feed to performance horses. Ensuring that pancreatic lipase function is optimal is necessary for the efficient use of these fats. In cases where pancreatic function is compromised, dietary management may need to be adjusted to ensure that the horse can still meet its nutritional requirements. In summary, equine pancreatic lipase is essential for the digestion and absorption of dietary fats in horses. It is involved in critical processes that contribute to the overall energy metabolism and nutritional health of the horse. While issues with pancreatic lipase are not commonly diagnosed in equine medicine, it remains an important enzyme for digestive health and energy balance.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.